Browse 1,565 thyroid cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Most thyroid cancers grow slowly and have some of the best outcomes of any cancer, which is why some small ones can now be safely monitored instead of removed right away. A small share behave very differently: cancers that stop responding to radioactive iodine, inherited medullary thyroid cancer, and the rare but aggressive anaplastic type. Targeted medicines matched to specific gene changes have opened new options for these groups.
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
for
Advanced Solid Tumors
Location: Fort Myers FL, Houston TX
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07172919
Phase 2, Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: Boston MA, New York NY, Montreal, Toronto,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06726148
Phase 1, Phase 2, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Boston MA, North Worcester MA, New Haven CT,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Voices: Messages of Wisdom and Hope in the Face of Illness
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07381179
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
for
Invasive Ductal Breast Carcinoma,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05837767
Recruiting
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07298096
Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Cannabis Oil for Pain Effectiveness
for
Cancer, Chronic Pain
Location: Hamilton
Sponsor: Aurora Cannabis Inc
Sex: All
Age: 25 - 70
Code: NCT03522467
Phase 2, Recruiting
Study of Endocrine-Related Conditions and Physiology
for
Endocrine Disease
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT03867448
Recruiting
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
for
Cancer
Location: Durham NC
Sponsor: VA Office of Research and Development
Sex: All
Age: 55+
Code: NCT05912257
Recruiting
myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports
for
Cancer, Relapsed Cancer, Refractory Cancer
Location: Sioux Falls SD
Sponsor: Cellworks Group Inc.
Sex: All
Age: 0+
Code: NCT05693831
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Quebec, Sherbrooke, White Plains NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
for
Refractory Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1 - 25
Code: NCT06006273
Phase 1, Recruiting
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
for
Cancer, Breakthrough Cancer Pain
Location: Berlin NJ
Sponsor: Tetra Bio-Pharma
Sex: All
Age: 18+
Code: NCT03564548
Phase 2, Recruiting
AMT-116 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Dallas TX
Sponsor: Multitude Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05725291
Phase 1, Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, New Haven CT, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited
Sex: All
Age: 18+
Code: NCT07266428
Phase 1, Phase 2, Recruiting
A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial